Healthcare
Deal focus: Everstone revisits India’s hospitals
Everstone Group acquires Sahyadri Hospitals to serve as the seed asset for a planned national healthcare delivery strategy
India's SigTuple gets $16m Series C
Trusted Insight, a US-based syndicate of institutional investors focused on alternatives, has led a $16 million Series C round for Indian healthcare artificial intelligence (AI) company SigTuple.
Bain-Piramal fund invests $144m in India's Panacea
India Resurgence Fund (India RF), a joint venture between Bain Capital Credit and Piramal Enterprises to invest in distressed assets in India, has agreed to invest up to INR9.9 billion ($144 million) in Indian pharmaceutical developer Panacea Biotec.
Everstone acquires IDFC-backed India hospital chain
India’s Everstone Group has agreed to acquire a controlling stake in Sahyadri Hospitals, a portfolio company of IDFC Alternatives that operates eight hospitals in Maharashtra, for an undisclosed amount.
Ekuinas exits Malaysia healthcare businesses
Malaysian government-backed private equity firm Ekuinas has exited its entire majority holdings in local healthcare players MediExpress and PMCare to Japan’s Sumitomo Corporation.
Chinese healthcare data management platform raises $74m
Miaojiankang, a China-based company that provides health data tracking, management, and analysis services through an online platform, has raised RMB500 million ($74 million) in a Series C round from China Pacific Insurance and Xiran Capital.
Longreach agrees Hong Kong medical devices buyout
The Longreach Group has announced the third investment from its recently closed third mid-market buyout fund, with an agreement to acquire contract development and manufacturing organization (CDMO) Quasar Engineering.
Everstone exits India's Rubicon to General Atlantic
General Atlantic has acquired Indian pharmaceutical developer Rubicon Research. Everstone Group, the company's controlling shareholder, will realize a 4.5x return on the deal.
EQT backs Southeast Asia healthcare benefits administrator
EQT has made an investment of undisclosed size in MHC Asia, a Southeast Asia-based healthcare benefits administrator that helps corporate clients customize health and wellness offerings.
Korea's Standigm raises $11.5m Series B
Mirae Asset Capital has led a $11.5 million Series B round for Standigm, a Korean drug discovery and development company that uses artificial intelligence (AI).
Tencent leads $74m round for China crowdfunding platform
Shuidi, the operator of Shuidichou, a Chinese crowdfunding platform for patients with critical medical conditions, has raised RMB500 million ($74 million) in a Series B round of funding led by existing investor Tencent Holdings.
Qiming leads $42m Series B for China cancer drug developer
Qiming Venture Partners has led a $42 million Series B round for Chinese cancer drug developer Abbisko.
Unison to exit Japan's Ayumi to Blackstone
The Blackstone Group has made its first transaction in Japan, agreeing to acquire Ayumi Pharmaceutical Corporation from Unison Capital and medical information site operator M3.
Everstone's healthcare platform makes first India investment
Everlife, an Asia healthcare investment platform managed by India’s Everstone Group, has made its first investment in India, committing an undisclosed amount to medical device manufacturer CPC Diagnostics.
HSBC, Singtel join $25m round for Singapore's CXA
Singapore-based digital health start-up CXA Group has raised $25 million in funding from a string of strategic backers, including HSBC and the Asia investment arms of Singtel and Sumitomo Corporation.
Advantech, CMBI lead Series C for China's InventisBio
Advantech Capital and CMB International, an investment unit of China Merchants Bank, have led a $70 million Series C funding round for InventisBio, a Chinese clinical stage biotech company.
UOB leads $65m Series B for Indonesia's Halodoc
Singapore-based United Overseas Bank (UOB) has led a $65 million Series B round for Indonesian healthcare technology provider Halodoc.
India's True North acquires Max Bupa for $72m
True North has acquired a 51% stake in Max Bupa Health Insurance, a joint venture between multinational insurance giant Bupa Group and Indian conglomerate Max India, for INR5.1 billion ($72 million).
J-Star's Japan Hospice Holdings set for Tokyo IPO
Japan Hospice Holdings, a hospice care platform created by J-Star through a series of acquisitions, is looking to raise JPY1.48 billion ($13.4 million) through a Tokyo IPO.
Chinese gym operator SuperMonkey raises $53.5m
Chinese gym operator SuperMonkey has raised RMB360 million ($53.5 million) in a Series D round led by Starquest Capital and Yao Capital, a sport-focused PE firm co-founded by former NBA star Yao Ming.
TPG-backed Pathology Asia invests Australia's Safe Work
TPG Capital Asia’s Pathology Asia platform has continued a regional roll-up strategy with an investment of undisclosed size in a minority stake in Australian drug testing specialist Safe Work Laboratories.
PE-backed Jinxin Fertility files for HK IPO
Jinxin Fertility, the assisted reproduction services division of China’s Jinxin Group that is backed by several private equity investors, has filed for an IPO in Hong Kong.
Lilly Asia Ventures closes Fund V at $750m hard cap
Lilly Asia Ventures (LAV) has closed its fifth healthcare fund – which operates globally but primarily backs companies with a China angle – at the hard cap of $750 million. It represents a meaningful step up in size from the $450 million raised for...
CCV leads Series B for Chinese AI player Shukun
Shukun, a Chinese company that provides artificial intelligence (AI) technology used in the treatment of cardiovascular diseases, has raised RMB200 million ($29 million) in a Series B round led by China Creation Ventures.